Previous 10 |
Artivion, Inc. (AORT) Q4 2021 Earnings Conference Call February 17, 2022, 04:30 PM ET Company Participants Brian Johnston - VP, IR, Gilmartin Group LLC J. Patrick Mackin - Chairman, President and CEO D. Ashley Lee - EVP, COO, and CFO Conference Call Participants Jeffrey Cohen - Ladenburg Thal...
Artivion Reports Fourth Quarter and Full Year 2021 Financial Results PR Newswire ATLANTA , Feb. 17, 2022 /PRNewswire/ -- Fourth Quarter and Recent Business Highlights: Achieved record revenue of $79.4 million in the fourth quarter 20...
Artivion Announces Release Date and Teleconference Call Details for Fourth Quarter and Full Year 2021 Financial Results PR Newswire ATLANTA , Feb. 3, 2022 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aorti...
Artivion Announces Publication of On-X® Mitral Heart Valve PROACT Study Results in The Annals of Thoracic Surgery Results Presented at the 2022 Annual Meeting for The Society of Thoracic Surgeons PR Newswire ATLANTA , Jan. 31, 2022 /PRNewswire/ -- Artivi...
News, Short Squeeze, Breakout and More Instantly...
Artivion Announces Release Date and Teleconference Call Details for Second Quarter 2024 Financial Results PR Newswire ATLANTA , July 25, 2024 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease...
2024-07-10 11:00:15 ET Frank Takkinen from Lake Street issued a price target of $30.00 for AORT on 2024-07-10 09:08:00. The adjusted price target was set to $30.00. At the time of the announcement, AORT was trading at $25.94. The overall price target consensus is at $30....